Insider Transactions in Q3 2025 at Incyte Corp (INCY)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,706
-3.48%
|
$248,302
$67.94 P/Share
|
|
Jul 16
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
785
-2.31%
|
$53,380
$68.36 P/Share
|
|
Jul 16
2025
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
983
-2.37%
|
$66,844
$68.36 P/Share
|
|
Jul 16
2025
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
1,340
-3.67%
|
$91,120
$68.36 P/Share
|
|
Jul 15
2025
|
Sheila A. Denton EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
8,184
+19.41%
|
-
|
|
Jul 15
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
703
-2.65%
|
$47,804
$68.25 P/Share
|
|
Jul 15
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,330
-11.16%
|
$229,770
$69.86 P/Share
|
|
Jul 15
2025
|
Sheila A. Denton EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,330
+10.04%
|
$213,120
$64.25 P/Share
|
|
Jul 15
2025
|
Matteo Trotta EVP, GM, Dermatology US |
BUY
Grant, award, or other acquisition
|
Direct |
5,261
+25.95%
|
-
|
|
Jul 15
2025
|
Matteo Trotta EVP, GM, Dermatology US |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-1.83%
|
$12,376
$68.25 P/Share
|
|
Jul 15
2025
|
Mohamed Khairie Issa EVP, Head of US Oncology |
BUY
Grant, award, or other acquisition
|
Direct |
8,769
+9.33%
|
-
|
|
Jul 15
2025
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,277
+10.33%
|
-
|
|
Jul 15
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,596
-1.66%
|
$108,528
$68.25 P/Share
|
|
Jul 15
2025
|
Pablo J Cagnoni President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
17,538
+6.95%
|
-
|
|
Jul 15
2025
|
Pablo J Cagnoni President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,628
-1.2%
|
$178,704
$68.25 P/Share
|
|
Jul 15
2025
|
Herve Hoppenot Special Advisor to the CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,713
-0.9%
|
$320,484
$68.25 P/Share
|
|
Jul 15
2025
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
1,141
-3.03%
|
$77,588
$68.25 P/Share
|
|
Jul 15
2025
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
1,192
-3.07%
|
$82,248
$69.86 P/Share
|
|
Jul 15
2025
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
6,430
+13.41%
|
-
|
|
Jul 15
2025
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
836
-2.33%
|
$56,848
$68.25 P/Share
|
|
Jul 15
2025
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
1,177
-3.17%
|
$81,213
$69.86 P/Share
|
|
Jul 15
2025
|
Thomas Tray Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,482
+15.57%
|
-
|
|
Jul 15
2025
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
583
-2.86%
|
$39,644
$68.25 P/Share
|
|
Jul 15
2025
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,107
+8.12%
|
-
|
|
Jul 15
2025
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,445
-1.24%
|
$98,260
$68.25 P/Share
|
|
Jul 15
2025
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
6,430
+5.69%
|
-
|
|
Jul 15
2025
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
563
-0.56%
|
$38,284
$68.25 P/Share
|
|
Jul 14
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,555
-1.6%
|
$107,295
$69.98 P/Share
|
|
Jul 14
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,952
-13.3%
|
$1,016,736
$68.47 P/Share
|
|
Jul 14
2025
|
Pablo J Cagnoni President, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,280
-0.58%
|
$88,320
$69.98 P/Share
|
|
Jul 14
2025
|
Herve Hoppenot Special Advisor to the CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,961
-0.94%
|
$342,309
$69.98 P/Share
|
|
Jul 14
2025
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
922
-2.32%
|
$63,618
$69.98 P/Share
|
|
Jul 14
2025
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
595
-1.58%
|
$41,055
$69.98 P/Share
|
|
Jul 14
2025
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
692
-3.28%
|
$47,748
$69.98 P/Share
|
|
Jul 14
2025
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,407
-1.2%
|
$97,083
$69.98 P/Share
|
|
Jul 14
2025
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
444
-0.44%
|
$30,636
$69.98 P/Share
|
|
Jul 03
2025
|
Barry P Flannelly EVP & General Manager US |
SELL
Open market or private sale
|
Direct |
10,903
-21.53%
|
$741,404
$68.15 P/Share
|
|
Jul 03
2025
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Open market or private sale
|
Direct |
8,617
-9.7%
|
$585,956
$68.16 P/Share
|
|
Jul 02
2025
|
Paula J Swain EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
6,285
-5.86%
|
$427,380
$68.17 P/Share
|
|
Jul 02
2025
|
Sheila A. Denton EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
599
-2.21%
|
$40,732
$68.61 P/Share
|
|
Jul 02
2025
|
Sheila A. Denton EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
599
+2.16%
|
$34,742
$58.06 P/Share
|
|
Jul 02
2025
|
Barry P Flannelly EVP & General Manager US |
SELL
Payment of exercise price or tax liability
|
Direct |
9,055
-15.17%
|
$615,740
$68.17 P/Share
|
|
Jul 02
2025
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,589
-8.98%
|
$788,052
$68.17 P/Share
|
|
Jul 02
2025
|
Steven H Stein EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,714
-10.16%
|
$864,552
$68.17 P/Share
|
|
Jul 02
2025
|
Thomas Tray Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
897
-4.08%
|
$60,996
$68.17 P/Share
|
|
Jul 02
2025
|
Herve Hoppenot Special Advisor to the CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
42,769
-7.51%
|
$2,908,292
$68.17 P/Share
|
|
Jul 02
2025
|
Vijay K Iyengar EVP, GMAPPS |
SELL
Payment of exercise price or tax liability
|
Direct |
6,809
-12.82%
|
$463,012
$68.17 P/Share
|
|
Jul 02
2025
|
William Meury Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+50.0%
|
-
|